titanium has been researched along with myricetin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Li, H; Liu, F; Liu, X; Qin, A; Qu, X; Tang, T; Tian, B; Wang, W; Wu, C; Zhai, Z; Zhu, Z | 1 |
1 other study(ies) available for titanium and myricetin
| Article | Year |
|---|---|
Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Flavonoids; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteolysis; Particle Size; Random Allocation; RANK Ligand; Titanium | 2015 |